Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug-Drug Interactions of E2086 in Healthy Subjects
NCT07766369Phase 1Recruiting
- Sponsor
- Eisai Co., Ltd.
- Start
- Aug 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial of E2086 (4 arms), sponsored by Eisai Co., Ltd. Primary endpoints: Area Under the Concentration-Time Curve From Time Zero to the Last Quantifiable Concentration, Area Under the Concentration-Time Curve From Time Zero to Infinity and 1 more. Started Aug 2026; status: recruiting.
02
Drugs
E2086
Beyond the preview
Go deeper on NCT07766369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07766369.